Grant✓ Small businesses may apply
Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
National Institutes of Health
- Opportunity #
- PAR-27-071
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.310
- Status
- posted
- Posted
- Jun 18, 2026
- Closes
- Jan 11, 2027
- Funding instrument
- Other
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Special district governments
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Public and State controlled institutions of higher education
- •County governments
- •State governments
- •Native American tribal governments (Federally recognized)
- •Public housing authorities/Indian housing authorities
- •Small businesses
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •For profit organizations other than small businesses
- •Private institutions of higher education
- •City or township governments
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Independent school districts
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Synopsis
As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First Program), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First Program supported genomic data generating centers. Applicants are encouraged to propose sequencing of existing pediatric cancer or congenital anomaly cohorts to elucidate the genetic contribution (somatic and/or germline) to childhood cancers, to investigate the genetic etiology of congenital anomalies, to study the molecular basis of the associations between congenital anomalies and increased cancer risk, or to expand the range of pediatric disorders included within the Kids First Data Resource. The program will accept applications that propose whole genome, exome, and transcriptome sequencing, as well as clinical-grade sequencing, long-read sequencing, proteomics, and epigenomic assays of tumor or affected tissue, when justified. Applicants are encouraged to propose cohorts to increase representation of existing Kids First Program projects. These data, and associated clinical and phenotypic data, will become part of the Kids First Data Resource Center for sharing with the research community.
Contact
National Institutes of Health · kidsfirst@od.nih.gov